Lobbying

Post Acute and Long Term Care Medicine Formerly Amda's latest lobbying report covers Q2 2026, at $10K. The four quarters Q4 2025–Q3 2026 total $30K. Its first report covers Q4 2022; the issues it reports most are Health Issues.

Post Acute and Long Term Care Medicine Formerly Amda

Latest quarter
No record
Q3 2026 · 0 reports
Last 12 months
$30K
Last 4 quarters
vs last quarter
−100.0%
Q3 2026 against the quarter before
First report
Q4 2022
The first quarter a report named it

Lobbying by quarter

Post Acute and Long Term Care Medicine Formerly Amda lobbying by quarter
Post Acute and Long Term Care Medicine Formerly Amda lobbying by quarter
QuarterAmountReports
Q4 2022$10K1
Q1 2023$10K1
Q2 2023$10K1
Q3 2023$10K1
Q4 2023$10K1
Q1 2024$10K1
Q2 2024$10K1
Q3 2024$10K1
Q4 2024$10K1
Q1 2025$10K1
Q2 2025$10K1
Q3 2025$10K1
Q4 2025$10K1
Q1 2026$10K1
Q2 2026$10K1
Q3 2026$00

By issue

  • Health issues$150K · 15 reports

An issue's amount splits each report's amount equally over the issues the report lists.

Who was lobbied

  • HOUSE OF REPRESENTATIVES15 reports
  • SENATE15 reports

Firms it paid

Firm
I Street Advocates$150K15 quarters

Former officials lobbying for it

No lobbyist with a covered position.

Lobbying reports

Filed by
07/09for Q2I Street Advocates$10K
04/14for Q1I Street Advocates$10K
01/08for Q4 2025I Street Advocates$10K
25/10/17for Q3 2025I Street Advocates$10K
25/07/10for Q2 2025I Street Advocates$10K
25/05/05for Q1 2025I Street Advocates$10K
25/01/08for Q4 2024I Street Advocates$10K
24/10/14for Q3 2024I Street Advocates$10K
24/07/12for Q2 2024I Street Advocates$10K
24/04/15for Q1 2024I Street Advocates$10K
24/01/05for Q4 2023I Street Advocates$10K
24/01/05for Q4 2023I Street AdvocatesUnder $5,000
24/01/05for Q4 2023I Street Advocates$10K
23/10/17for Q3 2023I Street Advocates$10K
23/07/17for Q2 2023I Street Advocates$10K
23/04/13for Q1 2023I Street Advocates$10K
23/01/24for Q4 2022I Street Advocates$10K